After recent market correction, Right Horizons' Anil Rego sees reasonable valuations in largecaps and overvaluation in the broader markets.
WABAG’s order book is 80 percent from government and flagship domestic projects
The pricing attractiveness of private banks stems from their current market multiples compared to their historical averages and growth rates, said Rohit Sarin.
India’s longer term economic fundamentals remain strong, and targeted efforts to strengthen domestic industries, manage inflation, and boost exports will be critical for long-term growth, said INDmoney's Ashish Kashyap.
Pramod Gubbi sees more downside risks to the equity markets given the valuations are still high and earnings don’t seem likely to bounce back anytime soon.
ITC needs to see bottoming pattern and consolidation before any meaningful rally on upside, said Ashish Kyal.
Though there has been 10 percent correction, at broader level markets are still in expensive zone especially in the context of the growth we have seen in H1FY25, said Sahil Shah.
As long as the Nifty 50 is trading above the 23,450 level, it is likely to continue its pullback rally upto the 100-day EMA level, which is currently placed at the 24,323 level, Sudeep Shah said.
Moving forward, the key focus of the market will be on earnings growth in the upcoming quarters. If there is a further slowdown in earnings growth, the major indices may enter a consolidation phase in the near term, said Max Life's Sachin Bajaj.
The sharp rally today could cause some stocks to hit new highs but the momentum is likely to fade, says veteran technical analyst
From a long term perspective, the India growth story seems to be on track with consistent reforms and proactive economic policies, said Jyoti Prakash Gadia of Resurgent India.
The current market correction has been good and healthy from a medium to long-term perspective. In any bull run such corrections are desired and welcome as they highlight the relevance of disciplined investing and strength of ones’ investment philosophy, said Swati Khemani.
Bank NIfty is likely to stay relatively stronger and relatively outperform the other indices, said Milan Vaishnav.
The October high inflation number is primarily driven by the inflation in food items while the other core items were in 3-4 percent price increase range. If the food prices inflation is to moderate then RBI may have room for a rate cut, Ashwini Shami said.
In case of pockets of opportunity for India if Trump renegotiates tariffs with China, Stefan Hofer feels it is too soon to argue that “China’s loss is India’s gain”.
Rajkumar Singhal thinks FIIs behaviour is more of a tactical adjustment rather than a structural shift, suggesting that if corporate earnings improve, FPIs may return to the Indian market.
Sorbh Gupta of Bajaj Finserv AMC believes rural consumption to lead the consumption demand revival from hereon.
The momentum indicators and oscillators suggest strong bearish momentum in the BSE Sensex. Hence, any sustainable move below the 200-day EMA zone of 77,400-77,300 will lead to sharp correction in the index, said Sudeep Shah.
Neeraj Chadawar of Axis Securities is cautious about the potential improvement in consumer spending for the second half of the year.
Ashish Kyal sees the new leg of up move in Zomato which smartly defended September low and rebounded
The currency impact from North eastern neighbours is manageable, and India’s economic outlook remains resilient amid the external noise, said Puneet Sharma.
The market is likely to rebound gradually, and a sustainable recovery will depend more on earnings growth rather than a sharp market correction, said Tata MF's Meeta Shetty.
Consumption is an important pillar of economic growth and consequently important for sustenance of the rally in the equity market, said Gaurav Dua of Sharekhan by BNP Paribas.
In an exclusive interview with Moneycontrol, Dr Reddy's CFO, M.V. Narasimham highlighted the company's plans on moving up the ranks in the Indian pharma market, areas of inorganic growth opportunities and prospects emerging from the US Biosecure Act.
RBI has not been taking interest rate decisions in sync with the Fed and Divam Sharma doesn’t expect that to happen either.